by [email protected] | Apr 25, 2019 | Cardiovascular, Publication
Abstract Authors: Nelson WW, Milentijevic D, Wang L, Baser O, Damaraju CV, Schein JR. Limited information exists regarding the relationship between international normalized ratio (INR) control/stability and the discontinuation of warfarin therapy among patients with...
by [email protected] | Apr 24, 2019 | Cardiovascular, Publication
Abstract Authors: Fox K, Wang L, Gandra SR, Quek RGW, Li L, Baser O. Background: Annual direct costs for cardiovascular (CV) diseases in the United States are approximately $195.6 billion, with many high-risk patients remaining at risk for major cardiovascular events...
by [email protected] | Apr 23, 2019 | Cardiovascular, Publication
Abstract Authors: Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND. The objective was to examine real-world treatment patterns of lipid-lowering therapies and their possible associated intolerance and/or ineffectiveness in patients with high cardiovascular disease...
by [email protected] | Apr 22, 2019 | Cardiovascular, Publication
Abstract Authors: Liu X, Xie L, Phatak H, Mardekian J, Tan W, Baser O, Ramacciotti E. This study examined warfarin therapy discontinuation and its risk factors among patients with unprovoked venous thromboembolism (VTE) in the US clinical practice setting. Adult...
by [email protected] | Apr 21, 2019 | Cardiovascular, Endocrine, Publication
Abstract Authors: Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND. Objective: To examine real-world treatment patterns of lipid-lowering treatment and their possible associated intolerance and/or ineffectiveness among patients with type 2 diabetes mellitus...
by [email protected] | Apr 19, 2019 | Cardiovascular, Publication
Abstract Authors: Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR. Background: Although efficacious in stroke prevention in non-valvular atrial fibrillation, many warfarin patients are sub-optimally managed. Objective: To evaluate the association of...
